Article Text

PDF

GW23-e0404
EARLY DETECTION OF SUBCLINICAL EPIRUBICIN-INDUCED CARDIOTOXICITY USING TWO-DIMENSIONAL SPECKLE TRACKING ECHOCARDIOGRAPHY
  1. Kang Yu1,
  2. Hong-min Lu2,
  3. Hai-Yan Chen1,
  4. Cui-Zhen Pan1,
  5. Shu Xianhong1
  1. 1Department of Echocardiography, Zhongshan Hospital of Fudan University; Shanghai Institute of Cardiovascular Disease, Shanghai, China
  2. 2Department of Oncology, Renji Hospital of Jiaotong University; Shanghai, China

    Abstract

    Objectives To assess the early subclinical epirubicin-induced cardiotoxicity during treatment of non-Hodgkin's lymphoma using two-dimensional (2D) speckle tracking echocardiography (STE).

    Methods Thirty-six patients (15 male/21 female) aged 56.88±9.76 with non-Hodgkin's lymphoma were included. Global longitudinal (GS), circumferential (CS) and radial strain (RS) were determined by 2D-STE before and 1 day after the last dose of epirubicin.

    Results Despite normal LVEF, after chemotherapy, GS, CS and RS reduced from −17.92±1.93% to −16.59±2.16% (p<0.01), from −20.46±3.39% to −18.01±2.16% (p<0.01), and from 23.90±5.10% to 21.86±6.03% (p>0.05) respectively. Among sex, age, cumulative doses of epirubicin (mg/m2), cigarette smoking, hypertension and diabetes, hypertension was the only negative predictor of LS decrease (p=0.036, 95% CI 0.03 to 4.06), and diabetes was the only negative predictor of CS decrease (p=0.009, 95% CI 1.16 to 7.30).

    Conclusions 2D-STE may help to detect Subclinical systolic myocardial abnormalities presented in asymptomatic non-Hodgin's disease patients shortly after epirubicin treatment.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.